title: Regulation of gastric emptying rate and its role in nutrient-induced GLP-1 secretion in rats after vertical sleeve gastrectomy.
abstract: Roux-en-Y gastric bypass (RYGB) and vertical sleeve gastrectomy (VSG) are effective weight loss surgeries that also improve glucose metabolism. Rapid, early rises of circulating insulin and glucagon-like peptide-1 (GLP-1) concentrations following food ingestion are characteristic of these procedures. The purpose of the current study was to test the hypothesis that postprandial hormone release is due to increased nutrient emptying from the stomach. Radioscintigraphy and chemical and radiolabeled tracers were used to examine gastric emptying in rat models of VSG and RYGB surgery. Intraduodenal nutrient infusions were used to assess intestinal GLP-1 secretion and nutrient sensitivity in VSG rats compared with shams. Five minutes after a nutrient gavage, the stomachs of RYGB and VSG rats were completely emptied, whereas only 6.1% of the nutrient mixture had emptied from sham animals. Gastric pressure was increased in VSG animals, and rats with this procedure did not inhibit gastric emptying normally in response to increasing caloric loads of dextrose or corn oil, and they did not respond to neural or endocrine effectors of gastric motility. Finally, direct infusion of liquid nutrients into the duodenum caused significantly greater GLP-1 release in VSG compared with shams, indicating that increases in GLP-1 secretion after VSG are the result of both greater gastric emptying rates and altered responses at the level of the intestine. These findings demonstrate greatly accelerated gastric emptying in rat models of RYGB and VSG. In VSG this is likely due to increased gastric pressure and reduced responses to inhibitory feedback from the intestine.
authors.affiliation: Division of Endocrinology and Metabolism, University of Cincinnati, Cincinnati, Ohio;
authors.forename: Adam P
authors.initials: AP
authors.lastname: Chambers
authors.forename: Eric P
authors.initials: EP
authors.lastname: Smith
authors.forename: Denovan P
authors.initials: DP
authors.lastname: Begg
authors.forename: Bernadette E
authors.initials: BE
authors.lastname: Grayson
authors.forename: Stephanie
authors.initials: S
authors.lastname: Sisley
authors.forename: Todd
authors.initials: T
authors.lastname: Greer
authors.forename: Joyce
authors.initials: J
authors.lastname: Sorrell
authors.forename: Lisa
authors.initials: L
authors.lastname: Lemmen
authors.forename: Kati
authors.initials: K
authors.lastname: LaSance
authors.forename: Stephen C
authors.initials: SC
authors.lastname: Woods
authors.forename: Randy J
authors.initials: RJ
authors.lastname: Seeley
authors.forename: David A
authors.initials: DA
authors.lastname: D'Alessio
authors.forename: Darleen A
authors.initials: DA
authors.lastname: Sandoval
mesh_terms: D000818:Animals; D001835:Body Weight / Q000187:drug effects / Q000502:physiology; D000077270:Exenatide; D005743:Gastrectomy / Q000379:methods*; D005746:Gastric Emptying / Q000187:drug effects / Q000502:physiology*; D005753:Gastric Mucosa / Q000187:drug effects / Q000378:metabolism*; D052216:Glucagon-Like Peptide 1 / Q000378:metabolism*; D007004:Hypoglycemic Agents / Q000494:pharmacology; D008297:Male; D010455:Peptides / Q000494:pharmacology; D019518:Postprandial Period / Q000502:physiology*; D051381:Rats; D020318:Rats, Long-Evans; D013270:Stomach / Q000187:drug effects; D014688:Venoms / Q000494:pharmacology
chemical_list: D007004:Hypoglycemic Agents; D010455:Peptides; D014688:Venoms; D052216:Glucagon-Like Peptide 1; D000077270:Exenatide
keywords: glucagon-like peptide-1